StockClub

URGN

URGNUroGen Pharma Ltd.$ --
UroGen Pharma Ltd.

UroGen Pharma Ltd.

URGN

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
51M USD
YoY +151.6%
Operating Income
-20M USD
YoY +45.1%
Net Income
-24M USD
YoY +46.2%
EPS
-0.47$
YoY +48.9%

Revenue

$51M
FY2024 Q2$40.6M
$40.6M
Q2
FY2024 Q3$65.8M
$65.8M
Q3
FY2024 Q4$90.4M
$90.4M
Q4
FY2025 Q1$20.3M
$20.3M
Q1
FY2025 Q2$44.5M
$44.5M
Q2
FY2025 Q3$72M
$72M
Q3
FY2025 Q4$109.8M
$109.8M
Q4
FY2026 Q1$51M
$51M
Q1
Actual
+$30.7M (+151.6%)

Net Income

$-23.6M
FY2024 Q2$-65.7M
$-65.7M
Q2
FY2024 Q3$-89.4M
$-89.4M
Q3
FY2024 Q4$-126.9M
$-126.9M
Q4
FY2025 Q1$-43.8M
$-43.8M
Q1
FY2025 Q2$-93.8M
$-93.8M
Q2
FY2025 Q3$-127.1M
$-127.1M
Q3
FY2025 Q4$-153.5M
$-153.5M
Q4
FY2026 Q1$-23.6M
$-23.6M
Q1
Actual
+$20.3M (+46.2%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$11.8M
Est:$11.5M
FY2020BEAT
$11.8M
FY2021MISS
Actual:$48M
Est:$48.1M
FY2021MISS
$48M
FY2022MISS
Actual:$64.4M
Est:$64.8M
FY2022MISS
$64.4M
FY2023MISS
Actual:$82.7M
Est:$85M
FY2023MISS
$82.7M
FY2024MISS
Actual:$90.4M
Est:$91M
FY2024MISS
$90.4M
FY2025MISS
Actual:$109.8M
Est:$111.9M
FY2025MISS
$109.8M

Analyst Estimates